Stephen DeCherney, MD, MPH

Stephen’s Biography

Stephen DeCherney, MD, MPH, is Professor of Medicine and former Professor (Adjunct) of Business in the Kenan-Flagler School of Business at University of North Carolina. Stephen is board certified in Internal Medicine and Endocrinology, Diabetes, and Metabolism and was named as one of the Best Doctors in America.

Stephen is also the Co-founder & Chairman of Helios Cinical, a company that provides its biopharmaceutical partners high quality research and data. Earlier in his career, Stephen was the CEO & a board member of Health Decisions, Inc., a full-service CRO specializing in clinical studies of therapeutics for women’s health. He also served as President, Global CRO at Quintiles Transnational Corporation and was an Independent Director of Theorem Clinical Research Company.

Currently, Stephen serves on the Board of KNOW Bio, a subsidiary of Novan that develops and produces nitric oxide-based therapies, and the Board of Directors of Robert F. Kennedy Human Rights. He also serves as a Trustee of the University of Delaware Research Foundation and the Christiana Care Health System,... Stephen DeCherney, MD, MPH, is Professor of Medicine and former Professor (Adjunct) of Business in the Kenan-Flagler School of Business at University of North Carolina. Stephen is board certified in Internal Medicine and Endocrinology, Diabetes, and Metabolism and was named as one of the Best Doctors in America.

Stephen is also the Co-founder & Chairman of Helios Cinical, a company that provides its biopharmaceutical partners high quality research and data. Earlier in his career, Stephen was the CEO & a board member of Health Decisions, Inc., a full-service CRO specializing in clinical studies of therapeutics for women’s health. He also served as President, Global CRO at Quintiles Transnational Corporation and was an Independent Director of Theorem Clinical Research Company.

Currently, Stephen serves on the Board of KNOW Bio, a subsidiary of Novan that develops and produces nitric oxide-based therapies, and the Board of Directors of Robert F. Kennedy Human Rights. He also serves as a Trustee of the University of Delaware Research Foundation and the Christiana Care Health System, and he is a US Representative for the William Harvey Research Foundation, Queen Mary University, London. Previously, Stephen was a Board Member of Symyx Corporation, also serving on their Audit Committee. He was a senior advisor to the London Genetics Company, Member of the Farmer Food Share Board of Trustees and Chairman of their Finance Subcommittee.

Stephen received a BA in Biology from Columbia College of Columbia University, New York, where he was awarded the Columbia College Alumni Achievement Award, which was granted to the “Senior Adjudged Most Outstanding in Qualities of Mind, Character, and Service to the College.” He also earned his MD from the Lewis Katz School of Medicine at Temple University, Philadelphia, and his MPH, Healthcare Policy and Management, from Columbia University School of Public Health. more less

Stephen’s Newsfeed

EIN Presswire

Industry Leaders Join e4 Board of Advisors

“We are thrilled to have these esteemed individuals join e4’s Board of Advisors,” said Niall Doherty, President and Co-Founder, e4. “e4 has grown consistently over the past 15 years...The e4 Board of Advisors will be instrumental in providing strategic guidance as we continue to put our clients first and position e4 for the future.”

Stephen’s Background

University of North Carolina School of Medicine

Professor of Medicine | Division of Endocrinology

2009 - Present

Chapel Hill, NC, USA

The Division of Endocrinology at UNC has a long tradition of excellence in basic science as well as translational and clinical research. Faculty research focuses on new modalities for treatment of diabetes and obesity, the factors that are responsible for improving bone mineral density, molecular mechanisms of obesity, and lipid metabolism, particularly as it relates to insulin secretion.

Helios Clinical

Co-Founder & Chairman

Jun 2021 - Present

New York, NY, USA

Helios Clinical Research has gathered a world-class clinical development team that engages patients and physicians to simplify their research journey to deliver our biopharmaceutical partners high quality data.

KNOW Bio

Chief Medical Officer

Sep 2019 - Present

Durham, NC, USA

KNOW Bio, based in the Research Triangle Park area of North Carolina, is a nitric oxide life science incubator for operating companies that utilize leveraged drug-development models by using small teams with high-quality service contractors and suppliers.

Health Decisions Inc

CEO

Dec 2014 - Mar 2016

Durham, NC, USA

Health Decisions is a full-service CRO that specializes in clinical studies of women's health therapeutics for indications and studies of diagnostics for all therapeutic areas.

Quintiles Transnational Corporation

President of Global CRO

Apr 2006 - 2008

Durham, NC, USA

Quintiles Transnational, now known as IQVIA, is the largest pharmaceutical outsourcing services company in the United States. The company is committed to bringing clients the best in creative problem solving, enabling healthcare companies to innovate, maximize opportunities and drive forward human health.

View all Hide

Current Board Positions

e4 Services

Board of Advisors

Nov 2020 - Present

Philadelphia, PA, USA

e4 is a leading national healthcare consulting and professional services company and provider of IT, Revenue Cycle, Clinical Optimization, HIM, CDI, and Coding solutions. e4 also specializes in complex program and change management, utlizing LEAN and proprietary engineered software to maximize outcomes and efficiencies.

KNOW Bio

Board of Directors

Aug 2018 - Present

Durham, NC, USA

KNOW Bio, based in the Research Triangle Park area of North Carolina, is a nitric oxide life science incubator for operating companies utilizing leveraged drug development models using small teams with high quality service contractors and suppliers.

View all Hide

Previous Board Positions

Pharm-Olam

Board of Directors

Jun 2020 - Dec 2021

Houston, TX, USA

Founded in 1994, Pharm-Olam is an award-winning CRO. It specialize in life-threatening therapeutic areas such as oncology, hematology, infectious disease, rare disease, allergy, and autoimmune.

Health Decisions Inc

Board of Directors

Apr 2016 - Jul 2021

Durham, NC, USA

Health Decisions is a full-service CRO specializing in clinical studies of therapeutics for women’s health indications and studies of diagnostics for all therapeutic areas.

View all Hide

Current Advisory Roles

Grant Avenue Capital

Executive Advisor

Feb 2021 - Present

New York, NY, USA

Grant Avenue Capital is a healthcare-focused private equity firm that partners with founders, entrepreneurs and management teams to implement its unique approach to investing. It seeks to build world-class companies that enhance patient health, improve the overall healthcare system and positively impact their communities.

A1A Capital

Executive Advisor

Jan 2017 - Present

New York, NY, USA

A1A Capital is an investment firm focused on making investments in leading middle market healthcare and consumer companies across North America.

Previous Advisory Roles

London Genetics Limited

Senior Advisor

London, UK

London Genetics Limited is a commercial company created to facilitate and manage partnerships between the healthcare industry and London centres of excellence in genetics and genomics-based medical research.

Philanthropy

RFK / Robert F. Kennedy Human Rights

Board of Directors

Dec 2016 - Present

New York, NY, USA

Robert F. Kennedy Human Rights, founded in 1968, is led by human rights activist and lawyer Kerry Kennedy and advocates for a more just and peaceful world. Working alongside local activists to ensure lasting positive change in governments and corporations, the RFK team includes leading attorneys, advocates, entrepreneurs and writers united by a commitment to social justice.

Christiana Care Health System

Fmr. Trustee

Wilmington, DE, USA

Christiana Care Health System is a not-for-profit health system that believes that the key to providing truly great health care is to partner with patients and their families, building a system of care that is effective, affordable and valuable to everyone.

View all Hide

Publications

The impact of post‐transplant diabetes mellitus on liver transplant outcomes

Co-author

Mar 2019

Post‐transplant diabetes mellitus (PTDM) is common after liver transplantation (LT). Yet, how PTDM relates to graft outcomes and survival needs elucidation as more individuals are transplanted for nonalcoholic fatty liver disease (NAFLD). Post‐transplant diabetes mellitus occurs rapidly in the post‐LT period and is a significant problem for both NAFLD and non‐NAFLD LT recipients.